MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
2.660
+0.050
+1.92%
Pre Market: 2.800 +0.14 +5.26% 04:55 05/13 EDT
OPEN
2.710
PREV CLOSE
2.610
HIGH
2.740
LOW
2.600
VOLUME
100
TURNOVER
0
52 WEEK HIGH
4.200
52 WEEK LOW
2.070
MARKET CAP
85.64M
P/E (TTM)
-6.8363
1D
5D
1M
3M
1Y
5Y
1D
ANIXA BIOSCIENCES ANNOUNCES POSTER PRESENTATION ON OVARIAN CANCER CAR-T CLINICAL TRIAL AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING
Reuters · 23h ago
Weekly Report: what happened at ANIX last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at ANIX last week (0428-0502)?
Weekly Report · 05/05 10:08
Weekly Report: what happened at ANIX last week (0421-0425)?
Weekly Report · 04/28 10:13
Weekly Report: what happened at ANIX last week (0414-0418)?
Weekly Report · 04/21 10:13
Anixa Biosciences Gets Notice Of Allowance From US Patent Office For CAR-T Technology
NASDAQ · 04/14 16:22
ANIXA BIOSCIENCES INC - RECEIVES NOTICE OF ALLOWANCE FOR CAR-T TECHNOLOGY PATENT
Reuters · 04/14 12:09
Anixa Biosciences receives notice of allowance for new patent from USPTO
TipRanks · 04/14 12:07
More
About ANIX
More
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.
Recently
Symbol
Price
%Change

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.